14TH ALA Conference: MLS® and lymphoedema: the focus of a seminar

09 June 2022 - Trade fairs & Congresses -

MLS® Laser Therapy and its devices are among the protagonists of the “14th ALA Conference” (Hobart – Tasmania) thanks to the participation of the local distributor Heal With Laser, a long-term partner of the Australian Lymphology Association, sponsor of the Conference and organiser of a pre-meeting speed on the topic “Using laser therapy to treat and manage lymphoedema: proof and practice”. 

The seminar, by Dr. Kate Perkins, owner of “Cancer Rehabilitation and Lymphatic Solutions” and a long-time user of the M6 device, presented an MLS® treatment method combined with other methods and some clinical cases solved using ASA-branded therapy.

“Already in the past, Dr. Sharon Tilley, Physiotherapist at the “Lymphoedema and Laser Therapy clinic” in Adelaide, has pointed out how MLS® could be a valuable support in the treatment of lymphoedema. Dr. Perkins’ speech - explains Giacomo Granozio, ASA Area Manager – further confirms its value, also emphasised by an articulate case history presented during the meeting”.

 

ALA 2022 pre-conference workshop on MLS Laser Therapy and lymphoedema
Lymphoedema and MLS Laser Therapy - Kate Perkins workshop

Catherine Norton, CEO and founder of Heal With Laser, adds:

“During the workshop, prominence was also given to the research carried out by the team from Hasselt University, consisting of Jolien Robijns, Joy Lodewijckx and Jeroen Mebis: we consider their research to be a guiding light in this sector. While photobiomodulation is widely recognised for the effective treatment of wounds, for the reduction of musculoskeletal pain and for the accelerations of healing processes, the innovative use of MLS® for the treatment of issues related to COVID-19 was also discussed during the seminar, as proven by Dr. Scott Sigman's clinical study. His work was truly pioneering and has allowed many European specialists to replicate his insight: laser therapy is now successfully used to treat post-COVID patients”.

You might also be interested in ...

See all articles

Supportive Care in Cancer - Springer
blog - 04/04/2022
M6 in the prevention of peripheral neuropathy caused by chemotherapy: a study
The clinical trial investigated the efficacy and safety of photobiomodulation therapy (PBMT) delivered by laser source (M6) in the prevention of chemotherapy-induced peripheral neuropathy (CIPN) in...
Effect of NIR Laser Therapy by MLS‐MiS Source on Fibroblast Activation by Inflammatory Cytokines in Relation to Wound Healing
blog - 12/04/2021
Research detects the anti-inflammatory effect of MiS on cells and molecules
The ASA device have an important anti-inflammatory effect, but it is also effective in controlling fibroblast activation induced by IL‐1β and TNF‐α, probably responsible for a detrimental effect on...
M8 laser treatment for pain due to COVID-19
blog - 09/04/2021
Journal Of Inflammation Research: MLS® Laser Therapy and the consequences of interstitial pneumonia caused by COVID-19
The results actually showed that patients undergoing MLS® Laser Therapy had a rapid recovery
ASAlaser @ Pecs - Hungary
News - 13/11/2024
MLS® Laser Therapy at the centre of a seminar at the Magyar Fisio Kongresszus
Thanks to the collaboration with the local distributor Procardia & Meddevice, present with its own stand, the company staff were able to meet long-standing customers and, at the same time, to...
Hilterapia and nerve function
Blog - 04/11/2024
Exploring the Effects of Hilterapia® on Skin Temperature and Nerve Function
A recent study conducted by Alayat et al. (2024) is the first to examine the effects of Hilterapia® - pulsed Nd:YAG laser source (1064nm) - on skin temperature and nerve function in healthy...
MLS Laser Therapy Speech in Brasov, Romania
News - 30/10/2024
Romania: ASA at the National Congress of Physical Medicine and Rehabilitation
MLS® Laser Therapy and some of its flagship devices could not miss out on attending the “National Congress of Physical Medicine and Rehabilitation” in Brasov (Romania, 16-19 October).